Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

SAGE Labs Partners with Cofactor Genomics

Published: Tuesday, October 08, 2013
Last Updated: Tuesday, October 08, 2013
Bookmark and Share
The partnership allows SAGE to offer gene expression profiling services as part of SAGEspeed® offering.

SAGE Labs Inc. announced that it will begin offering RNA-sequencing services as part of its SAGEspeed Custom Model Creation Platform. The sequencing and analysis portion of the RNA-seq studies will be performed by Cofactor Genomics, a leader in the field of RNA sequencing and analysis (RNA-seq).

Through the agreement, SAGE Labs, who has rights to use Zinc Finger Nuclease (ZFN) and CRISPR/cas9 technology to generate genetically modified mice, rats, and rabbits, will now be able to provide gene expression profiles on the resulting animal models. This enables researchers to identify genes that are turned on or off as a result of the genomic modification.

Clients of the RNA-seq services will receive an in-depth representation of expressed loci and differential expression of genes. These expression profiles lay the foundation for future experiments involving the animal model, for instance, studying how gene expression will change in response to certain treatments or conditions.

Kevin Gamber, PhD, Director of Marketing at SAGE Labs, explained “SAGE is very excited to offer RNA-seq expression profiling as a part of our SAGEspeed custom model generation services. Through this valuable addition, customers will not only receive their custom animal model, but also the relative gene expression level of every gene. You’ll instantly be able to know which genes and pathways are potentially affected in your model.”

Cofactor’s COO, Jon Armstrong, noted “Cofactor is pleased to offer our expertise in RNA sequencing to build off of SAGE’s genetically engineered models. Genomic characterization is the next step after animal model creation and RNA expression analysis will provide insight and confidence to an already excellent service. SAGE is not only a leader in the field but a fellow St. Louis company and we are delighted to be collaborating with them.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

SAGE® Labs and Autism Speaks Expand Collaboration
Unexpected gene functions shown in initial studies.
Monday, August 06, 2012
Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
New Medication Shows Promise Against Liver Fibrosis in Animal Studies
Liver fibrosis is a gradual scarring of the liver that puts people at risk for progressive liver disease and liver failure.
Raw Eggs Deemed Safe to Eat
A report published today by the Advisory Committee on the Microbiological Safety of Food (ACMSF) into egg safety has shown a major reduction in the risk from salmonella in UK eggs.
Monitoring TTX Toxin in Shellfish
In a number of small studies, mussels and oysters from the eastern and northern part of the Oosterschelde in Holland were found to contain tetrodotoxin (TTX).
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Detecting Alzheimer's with Smell Test
Odour identification test may offer low-cost alternative for predicting cognitive decline and detecting early-stage Alzheimer’s disease.
Antibody Drug Shows Promise in HIV Treatment
Researchers are a step closer to an alternative HIV treatment that has the potential for lasting effects and less frequent dosing.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!